DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hædersdal S, Lund A, Nielsen-Hannerup E. et al.
The role of glucagon in the acute therapeutic effects of SGLT2 inhibition.
Diabetes 2020;
69 (12) 2619-2629
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.